Resveratrol

Resveratrol

SCHEMBL19425

Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 6/20 1.00
KDM4E B2RXH2 5/20 1.00
TTR P02766 5/20 1.00
LMNA P02545 4/20 1.00
MEN1 O00255 4/20 1.00
MAPT P10636 4/20 1.00
KMT2A Q03164 4/20 1.00
CYP1A1 P04798 4/20 1.00
PTGS2 P35354 4/20 1.00
CYP1B1 Q16678 4/20 1.00
ALOX5 P09917 4/20 1.00
ALDH1A1 P00352 3/20 1.00
TP53 P04637 3/20 1.00
CYP1A2 P05177 3/20 1.00
CYP3A4 P08684 3/20 1.00
CYP2C9 P11712 3/20 1.00
HPGD P15428 3/20 1.00
SMN1; SMN2 Q16637 3/20 1.00
HIF1A Q16665 3/20 1.00
HSD17B10 Q99714 3/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Resveratrol SCHEMBL2300985 1.00 PTGS1 (1.00) PTGS1KDM4ETTRLMNAMEN1
Cis-Resveratrol SCHEMBL1931746 1.00 PTGS1 (1.00) PTGS1KDM4ETTRLMNAMEN1
Resveratrol SCHEMBL17629801 1.00 PTGS1 (1.00) PTGS1KDM4ETTRLMNAMEN1
Resveratrol SCHEMBL15106855 1.00 PTGS1 (1.00) PTGS1KDM4ETTRLMNAMEN1
Resveratrol SCHEMBL19426 1.00 PTGS1 (1.00) PTGS1KDM4ETTRLMNAMEN1
Resveratrol SCHEMBL3704258 1.00 PTGS1 (1.00) PTGS1KDM4ETTRLMNAMEN1
Resveratrol SCHEMBL20164915 1.00 PTGS1 (1.00) PTGS1KDM4ETTRLMNAMEN1
Resveratrol SCHEMBL31096991 0.97 PTGS1 (0.95) PTGS1KDM4ETTRLMNAMEN1
Resveratrol SCHEMBL3405900 0.97 PTGS1 (0.95) PTGS1KDM4ETTRLMNAMEN1
Resveratrol SCHEMBL22469907 0.97 PTGS1 (0.95) PTGS1KDM4ETTRLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 82646 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746880-A2 METHODS OF TREATING DILATED CARDIOMYOPATHY Regencor, Inc. (US) 2026-05-27 EP claimed
EP-4746864-A1 C5 KETONE COMPOSITIONS AND RELATED METHODS FOR TREATING METABOLIC DYSFUNCTION Keto Innovations, LLC (US) 2026-05-27 EP claimed
CN-122074654-A Microcapsule type composition for reducing blood sugar and preparation method and application thereof 2026-05-26 CN claimed
CN-122075567-A A composition containing herba Silybi Mariani extract and Akk bacteria 2026-05-26 CN claimed
CN-121378801-B Photo-crosslinking double-network hydrogel for promoting skin wound healing and preparation method thereof Shandong second people's Hospital (Shandong ear nose throat hospital, Shandong ear nose throat Research Institute) (CN) 2026-05-26 CN claimed
CN-122084707-A 25-Hydroxy vitamin D3Molecularly imprinted electrochemical sensor, preparation method and application thereof 2026-05-26 CN claimed
CN-118179263-B Preparation method of copolymer ultrafiltration membrane with bonding structure HEBEI UNIVERSITY OF TECHNOLOGY (CN) 2026-05-26 CN claimed
CN-122081420-A Method for preparing resveratrol by double-bacterium co-culture system 2026-05-26 CN claimed
CN-122081085-A Fungus and application thereof as well as method for preparing resveratrol 2026-05-26 CN claimed
CN-122075778-A Hydrogel dressing for repairing oral wound surface and preparation method thereof 2026-05-26 CN claimed
EP-0925068-A1 PHARMACEUTICAL COMPOSITION CONTAINING POLYPHENOLS FROM GRAPES, IN PARTICULAR RESVERATROL, AND YEAST EXTRACTS LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA S.P.A. (IT) 1999-06-30 EP claimed
WO-1999015148-A1 RESORCINOL DERIVATIVES PFIZER PRODUCTS INC. (US) 1999-04-01 WO claimed
EP-0904774-A1 Resorcinol derivatives Pfizer Products Inc. (US) 1999-03-31 EP claimed
WO-1999004747-A2 COSMETIC COMPOSITIONS UNILEVER PLC (GB) 1999-02-04 WO claimed
WO-1999003816-A1 COMPOSITIONS BASED ON RESVERATROL CAUDALIE (FR) 1999-01-28 WO claimed
WO-1999001148-A1 PHARMACEUTICAL COMPOSITION CONTAINING POLYPHENOLS FROM GRAPES, IN PARTICULAR RESVERATROL, AND YEAST EXTRACTS LABORATORIO ITALIANO BIOCHIMICO FARMACEUTICO LISAPHARMA S.P.A. (IT) 1999-01-14 WO claimed
WO-1998041113-A2 MEDICAL FOOD FOR DIABETICS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1998-09-24 WO claimed
US-5747536-A ATHERIOSCLEROSIS AND CARDIOVASCULAR DISORDERS SIGMA-TAU INDUSTRIE FARMACEUTICHE RIUNITE S.P.A. (IT) 1998-05-05 US claimed
WO-1997018715-A1 USE OF ALUMINIUM CHLORIDE AS A RESVERATROL SYNTHESIS ELICITOR LABORATOIRES GOEMAR S.A. (FR) 1997-05-29 WO claimed
EP-0773020-A2 Pharmaceutical compositions containing L-carnitine or derivatives thereof in combination with resveratrol or derivatives thereof, for the prophylaxis and treatment of cardiovascular disorders, peripheral vascular diseases and peripheral diabetic neuropathy Sigma-Tau Industrie Farmaceutiche Riunite S.p.A. (IT) 1997-05-14 EP claimed